Published on 25/06/2015

Societe Generale announces the completion of the sale of 7.04% of Sopra Steria Group's share capital

Societe Generale announces the completion of the sale of 7.04% of Sopra Steria Group’s share capital held through its 100% owned subsidiary Geninfo.

Societe Generale has been a shareholder in Sopra Group and then Sopra Steria Group since 1996 and wishes to maintain the excellent relationship cultivated between both groups over the years.

This transaction is part of the disinvestment strategy from industrial holdings, initiated by Societe Generale Group a few years ago.

Geninfo sold its entire stake in Sopra Steria Group representing 1.4 million shares and 7.04% of the  capital, for an amount of around 111 millions d’euros.

Sopra GMT (Pasquier and Odin families and the historical Managers) acquired through this placement, 700,000 shares corresponding to 3.43% of Sopra Steria Group share capital for a total amount of 54 million euros.

Sopra Steria Group acquired, in the frame of the placement, 300,000 shares representing 1.47% of its share capital, for a total amount of 23 million euros.

The remainder, i.e. 434,700 shares corresponding to 2.13% of the share capital, has been subscribed by institutional investors.

The sale of shares has been offered in a private placement executed by way of an accelerated bookbuilding at a price of 77.25 euros per share.

The bookbuilding was managed by Societe Generale Corporate & Investment Banking, Sole Bookrunner on the transaction.


This announcement is for information purposes only and does not constitute an offer to sell or a solicitation to buy any securities, and the offer of Sopra Steria Group shares by [Societe Generale through its subsidiary Geninfo] does not constitute a public offering in any jurisdiction, including in France.

This communication is for distribution in the United Kingdom only to (i) investment professionals falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (ii) high net worth entities and other persons to whom it may lawfully be communicated, falling within article 49(2)(a) to (d) of the Order (all such persons together being referred to as "relevant persons").

The offer and sale of the securities referred to in this announcement has not been, nor will be, registered under the United States Securities Act of 1933 (the "Securities Act") and the securities may not be offered or sold in the United States absent such registration or an applicable exemption from the registration requirements of the Securities Act. There will be no public offering of the securities in the United States in connection with this transaction.

Any investment decision to buy shares in Sopra Steria Group must be made solely on the basis of publicly available information regarding Sopra Steria Group. Such information is not the responsibility of Societe Generale or Geninfo.

Release, publication or distribution of this press release is forbidden in any country where it would violate applicable laws or regulations.